Articles

Search all Gastric Cancer articles

Filter by

Volume:

Sort by

Date published:

New to old Old to new

Showing 51-100 of 2,084 articles

Long-term oncological outcomes of 3D versus 2D laparoscopic gastrectomy for gastric cancer: a randomized clinical trial
Qing Zhong
Jun-Yu Chen
Chao-Hui Zheng
Original Article 20 February 2024 Pages: 598 - 610
Nishi memorial award in gastric cancer

Announcement 14 February 2024 Pages: 400 - 400
Sustained exposure to Helicobacter pylori induces immune tolerance by desensitizing TLR6
Xiulin Zhang
Yang He
Changlong Li
Original Article Open access 04 February 2024 Pages: 324 - 342
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial
Zev A. Wainberg
Yoon-Koo Kang
Peter C. Enzinger
Original Article Open access 03 February 2024 Pages: 558 - 570
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial
Yoon-Koo Kang
Min-Hee Ryu
Narikazu Boku
Original Article Open access 28 January 2024 Pages: 375 - 386
Inhibition of proprotein convertases activity results in repressed stemness and invasiveness of cancer stem cells in gastric cancer
Anissa Zaafour
Lornella Seeneevassen
Christine Varon
Original Article 27 January 2024 Pages: 292 - 307
Chromosomal copy number amplification-driven Linc01711 contributes to gastric cancer progression through histone modification-mediated reprogramming of cholesterol metabolism
Ben Yue
Jianjun Chen
Chunchao Zhu
Original Article 25 January 2024 Pages: 308 - 323
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models
Elisabetta Puliga
Chiara De Bellis
Silvia Giordano
Original Article Open access 23 January 2024 Pages: 473 - 483
N⁶-methyladenosine-modified MIB1 promotes stemness properties and peritoneal metastasis of gastric cancer cells by ubiquitinating DDX3X
Peng Xu
Kanghui Liu
Diancai Zhang
Original Article 22 January 2024 Pages: 275 - 291
Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study)
Masanori Tokunaga
Nozomu Machida
Masanori Terashima
Original Article 19 January 2024 Pages: 580 - 589
Diagnostic performance of deep-learning-based virtual chromoendoscopy in gastric neoplasms
Sho Suzuki
Yusuke Monno
Masatoshi Okutomi
Original Article 19 January 2024 Pages: 539 - 547
Dose–response association between cigarette smoking and gastric cancer risk: a systematic review and meta-analysis
Matteo Rota
Irene Possenti
Alessandra Lugo
Review Article 17 January 2024 Pages: 197 - 209
CEACAM5 and TROP2 define metaplastic and dysplastic transitions in human antral gastric precancerous lesions and tumors
Bogun Jang
Su-Hyung Lee
James R. Goldenring
Original Article 14 January 2024 Pages: 263 - 274
Tumor-infiltrating monocytic myeloid-derived suppressor cells contribute to the development of an immunosuppressive tumor microenvironment in gastric cancer
Chikanori Tsutsumi
Kenoki Ohuchida
Masafumi Nakamura
Original Article 13 January 2024 Pages: 248 - 262
Sex-dependent different clinicopathological characterization of Epstein–Barr virus-associated gastric carcinoma: a large-scale study
Ji-Hyun Kim
Nayoung Kim
Soyeon Ahn
Original Article Open access 11 January 2024 Pages: 221 - 234
Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704)
Yukinori Kurokawa
Yuichiro Doki
Masanori Terashima
Original Article Open access 05 January 2024 Pages: 366 - 374
The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry
Ryugo Teranishi
Tsuyoshi Takahashi
Toshimasa Tsujinaka
Original Article Open access 25 December 2023 Pages: 355 - 365
Oncological outcomes of conversion therapy in gastric cancer patients with peritoneal metastasis: a large-scale retrospective cohort study
Zhongyin Yang
Sheng Lu
Zhenggang Zhu
Original Article Open access 24 December 2023 Pages: 387 - 399
FBXW7 regulates the sensitivity of imatinib in gastrointestinal stromal tumors by targeting MCL1
Xiyu Wu
Masaaki Iwatsuki
Hideo Baba
Original Article 24 December 2023 Pages: 235 - 247
Diagnosing and grading gastric atrophy and intestinal metaplasia using semi-supervised deep learning on pathological images: development and validation study
Shuangshuang Fang
Zhenyu Liu
Wei Wei
Original Article Open access 14 December 2023 Pages: 343 - 354
Effects of RAD50 SNP, sodium intake, and H. pylori infection on gastric cancer survival in Korea
Jung Hyun Kwak
Chang Soo Eun
Hyun Ja Kim
Original Article 09 December 2023 Pages: 210 - 220
Automatic surgical phase recognition-based skill assessment in laparoscopic distal gastrectomy using multicenter videos
Masaru Komatsu
Daichi Kitaguchi
Masaaki Ito
Original Article 01 December 2023 Pages: 187 - 196
Gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy
Bingzhi Wang
Yongjian Zhu
Liyan Xue
Original Article 29 November 2023 Pages: 86 - 101
Clinical outcomes of Epstein–Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy
Eo Jin Kim
Heejung Chae
Yoon-Koo Kang
Original Article 25 November 2023 Pages: 146 - 154
Randomized controlled trial comparing the costs of gastric cancer screening systems between serological risk-based upper gastrointestinal endoscopy and the existing barium photofluorography: gastric cancer screening labeled by serum examination in place of aged gastric cancer organized screening systems (GALAPAGOS study)
Takuji Gotoda
Hideki Ishikawa
Yutaka Matsuyama
Original Article 25 November 2023 Pages: 36 - 48
5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer
Takaki Yoshikawa
Masanori Terashima
Mitsuru Sasako
Original Article 21 November 2023 Pages: 155 - 163
Helicobacter pylori testing prior to or at gastric cancer diagnosis and survival in a diverse US patient population
Katherine S. Garman
HannahSofia Brown
Meira Epplein
Original Article 20 November 2023 Pages: 28 - 35
Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry
Pablo Pérez-Wert
Ana Custodio
the AGAMENON-SEOM study group
Original Article 15 November 2023 Pages: 131 - 145
Effect of preoperative chemotherapy on the histopathological classification of gastric cancer
I. A. Caspers
H. D. Biesma
N. C. T. van Grieken
Original Article Open access 10 November 2023 Pages: 102 - 109
Acknowledgment to Reviewers

Acknowledgment to Reviewers 08 November 2023 Pages: 1074 - 1075
Ethnic-specific associations between body mass index and gastric cancer: a Mendelian randomization study in European and Korean populations
Sangjun Lee
Sue K. Park
Original Article 02 November 2023 Pages: 19 - 27
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study
Choong-kun Lee
Jii Bum Lee
Sun Young Rha
Original Article 31 October 2023 Pages: 118 - 130
N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation
Rongjun Xie
Longfei Liu
Guoxin Li
Original Article Open access 28 October 2023 Pages: 49 - 71
DNA mismatch repair deficiency and outcomes of patients with locally advanced gastric cancer treated with preoperative docetaxel, oxaliplatin, and S-1 plus surgery and postoperative S-1 or surgery plus postoperative S-1: a sub-analysis of the phase 3 PRODIGY trial
Jaewon Hyung
Hyungwoo Cho
Yoon-Koo Kang
Original Article 27 October 2023 Pages: 110 - 117
A nonrandomized controlled trial: long-term outcomes of LATG/LAPG for cStage I gastric cancer: Japan Clinical Oncology Group Study JCOG1401
Chikara Kunisaki
Hitoshi Katai
the Stomach Cancer Study Group of Japan Clinical Oncology Group
Original Article 25 October 2023 Pages: 164 - 175
Identifying the best candidates for reduced port gastrectomy
Jae Hun Chung
Jawon Hwang
Hyoung-Il Kim
Original Article Open access 24 October 2023 Pages: 176 - 186
Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor–adipocyte interaction indicating an altered immune response
Bianca Grosser
Christian M. Heyer
Bruno Märkl
Original Article Open access 24 October 2023 Pages: 72 - 85
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer
Florian Lordick
Salah-Eddin Al-Batran
For the Germany Society of Hematology and Medical Oncology (DGHO, Austrian Society of Hematology and Oncology (OeGHO), Swiss Society of Hematology (SSH), Swiss Society of Medical Oncology (SGMO); in collaboration with the Arbeitsgemeinschaft Internistische Onkologie (AIO) of the German Cancer Society
Special Article Open access 17 October 2023 Pages: 6 - 18
National guidelines for gastric cancer: redundant or needed?
Florian Lordick
Bernhard Wörmann
Editorial Open access 17 October 2023 Pages: 3 - 5
The Magic Flute is a Singspiel, not an opera? My thoughts about the German, Austrian and Swiss Guidelines for Systemic Treatment of Gastric Cancer
Yasuhiro Kodera
Editorial 13 October 2023 Pages: 1 - 2
The clinical importance of the host anti-tumour reaction patterns in regional tumour draining lymph nodes in patients with locally advanced resectable gastric cancer: a systematic review and meta-analysis
Elzbieta Budginaite
Maximilian Kloft
Heike I. Grabsch
Review Article Open access 30 September 2023 Pages: 847 - 862
SOX combined with sintilimab versus SOX alone in the perioperative management of locally advanced gastric cancer: a propensity score–matched analysis
Xingmao Huang
Jingquan Fang
Pengfei Yu
Original Article Open access 28 September 2023 Pages: 1040 - 1050
LncRNA expression signature identified using genome-wide transcriptomic profiling to predict lymph node metastasis in patients with stage T1 and T2 gastric cancer
Zhe-bin Dong
Han-ting Xiang
Chao Liang
Original Article Open access 10 September 2023 Pages: 947 - 957
CD45⁻ erythroid progenitor cells promote lymph node metastasis in gastric cancer by inducing a hybrid epithelial/mesenchymal state in lymphatic endothelial cells
Jing-Yun Wen
Xing Li
Chun-Kui Shao
Original Article 07 September 2023 Pages: 918 - 933
Soluble PD-L1 as a diagnostic and prognostic biomarker in resectable gastric cancer patients
Mihaela Chivu-Economescu
Vlad Herlea
Dan G. Duda
Original Article 05 September 2023 Pages: 934 - 946
Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer–single institutional experience
Mashiro Okunaka
Akihito Kawazoe
Kohei Shitara
Original Article 04 September 2023 Pages: 1030 - 1039
Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study
Tae-Hwan Kim
Jin-Hyuk Choi
Seung-Soo Sheen
Original Article 30 August 2023 Pages: 1012 - 1019
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study
Ryohei Kawabata
Keisho Chin
Kensei Yamaguchi
Original Article Open access 23 August 2023 Pages: 1020 - 1029
Prognostic value of post-operative serum procalcitonin in gastric adenocarcinoma patients undergoing radical gastrectomy: propensity score matching analysis of extended cohort from a prospective bi-center study
Hua Xiao
Yongzhou Huang
Jia Luo
Original Article Open access 14 August 2023 Pages: 1051 - 1062
PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment
Yi Liu
Daoyan Wei
Xiangsheng Zuo
Original Article Open access 12 August 2023 Pages: 904 - 917